Table 1.
Resistance patterns of SE clinical strains (%) by comparison of biofilm producers versus non-biofilm producers.
| Antimicrobial agents | Biofilms producers (%) | Non-biofilm producers (%) |
|---|---|---|
| AMC | 94 | 78 |
| AMP | 100 | 97 |
| KZ | 94 | 78 |
| CTX | 41 | 29 |
| CIP | 81 | 46 |
| DA | 76 | 49 |
| C | 40 | 26 |
| E | 84 | 63 |
| CN | 87 | 61 |
| IPM | 93 | 78 |
| LEV | 42 | 27 |
| OX | 94 | 78 |
| P | 99 | 96 |
| RD | 1 | 3 |
| TE | 13 | 24 |
| SXT | 86 | 54 |
| VA | 0 | 0 |